Home LiteratureArticle Details
PMID: 14642185 Published · ppublish English Journal Article

Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors.

Current infectious disease reports ·Vol. 5 ·No. 6 ·2003-12-00 ·Pages 459-466

Eguia JM, Chambers HF

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has been isolated from patients in the community. Some of these strains may have origins in the hospital, but others appear to be novel and unrelated to known hospital strains. Community MRSA strains have several distinguishing characteristics that may enable them to more readily colonize and infect otherwise healthy individuals. This article reviews recent publications addressing the epidemiology of MRSA in the community, risk factors associated with carriage, potentially associated virulence factors, and concepts of strain fitness as they pertain to MRSA. MRSA likely will be an increasingly important pathogen in the community.

Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Eguia Jose M.
Division of Infectious Diseases, San Francisco General Hospital, 1001 Potrero Avenue, Box 0811, University of California, San Francisco, CA 94143, USA. jeguia@itsa.ucsf.edu
Chambers Henry F.
References (62)
62 references, click to expand
  1. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.
    Clin Infect Dis. 2002 Oct 1;35(7):819-24 PMID: 12228818
  2. Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases.
    J Clin Microbiol. 2001 Dec;39(12):4349-56 PMID: 11724844
  3. Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999.
    Microb Drug Resist. 2003 Summer;9(2):155-60 PMID: 12820800
  4. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.
    JAMA. 1998 Feb 25;279(8):593-8 PMID: 9486753
  5. Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen.
    Diagn Microbiol Infect Dis. 2001 May-Jun;40(1-2):1-4 PMID: 11448556
  6. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community.
    J Clin Microbiol. 2002 Nov;40(11):4289-94 PMID: 12409412
  7. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population.
    Pediatr Infect Dis J. 2002 Oct;21(10):917-22 PMID: 12394812
  8. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children.
    Pediatr Infect Dis J. 2002 Oct;21(10):910-7 PMID: 12394811
  9. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.
    Clin Infect Dis. 1999 Nov;29(5):1128-32 PMID: 10524952
  10. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus.
    Ann Intern Med. 1982 Sep;97(3):309-17 PMID: 7114627
  11. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.
    Lancet. 2002 Mar 2;359(9308):753-9 PMID: 11888586
  12. The emergence and evolution of methicillin-resistant Staphylococcus aureus.
    Trends Microbiol. 2001 Oct;9(10):486-93 PMID: 11597450
  13. New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community.
    Curr Opin Infect Dis. 2002 Aug;15(4):407-13 PMID: 12130938
  14. Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community.
    BMJ. 2002 Jun 8;324(7350):1365-6 PMID: 12052803
  15. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia.
    J Clin Microbiol. 2000 Nov;38(11):3926-31 PMID: 11060046
  16. Epidemiology of methicillin-resistant Staphylococcus aureus at a children's hospital.
    Infect Control Hosp Epidemiol. 2003 Jun;24(6):427-30 PMID: 12828319
  17. Staphylococcus aureus nasal carriage in the community: a survey from central Italy.
    Epidemiol Infect. 2002 Oct;129(2):417-20 PMID: 12403117
  18. Exotoxins of Staphylococcus aureus.
    Clin Microbiol Rev. 2000 Jan;13(1):16-34, table of contents PMID: 10627489
  19. Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a "shooting gallery".
    Am J Med. 1986 May;80(5):770-6 PMID: 3635355
  20. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia.
    Clin Infect Dis. 2002 Jun 1;34(11):1431-9 PMID: 12015688
  21. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory.
    Med J Aust. 1996 Jun 17;164(12):721-3 PMID: 8668078
  22. The biological cost of antibiotic resistance.
    Curr Opin Microbiol. 1999 Oct;2(5):489-93 PMID: 10508723
  23. Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children.
    Pediatr Infect Dis J. 2002 Oct;21(10):988-9 PMID: 12394827
  24. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999.
    MMWR Morb Mortal Wkly Rep. 1999 Aug 20;48(32):707-10 PMID: 21033181
  25. Low prevalence of methicillin-resistant strains among Staphylococcus aureus colonizing young and healthy members of the community in Portugal.
    Microb Drug Resist. 2001 Fall;7(3):237-45 PMID: 11759085
  26. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community.
    JAMA. 2001 Sep 12;286(10):1201-5 PMID: 11559265
  27. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission.
    Infect Control Hosp Epidemiol. 2003 Jun;24(6):409-14 PMID: 12828316
  28. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003.
    MMWR Morb Mortal Wkly Rep. 2003 Feb 7;52(5):88 PMID: 12588006
  29. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.
    Clin Infect Dis. 2001 Oct 1;33(7):990-6 PMID: 11528570
  30. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors.
    Clin Infect Dis. 2003 Jan 15;36(2):131-9 PMID: 12522744
  31. Strains of Staphylococcus aureus obtained from drug-use networks are closely linked.
    Clin Infect Dis. 2002 Sep 15;35(6):671-7 PMID: 12203163
  32. Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually "healthcare associated".
    Infect Control Hosp Epidemiol. 2003 Jun;24(6):436-8 PMID: 12828321
  33. Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2002 Dec;50(6):825-31 PMID: 12461000
  34. Community-acquired methicillin-resistant Staphylococcus aureus infections--Michigan.
    MMWR Morb Mortal Wkly Rep. 1981 May 1;30(16):185-7 PMID: 6789075
  35. CDC definitions for nosocomial infections, 1988.
    Am J Infect Control. 1988 Jun;16(3):128-40 PMID: 2841893
  36. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance.
    CMAJ. 2001 Jul 10;165(1):21-6 PMID: 11468949
  37. The Genomic Aspect of Virulence, Sepsis, and Resistance to Killing Mechanisms in Staphylococcus aureus.
    Curr Infect Dis Rep. 2002 Oct;4(5):400-410 PMID: 12228026
  38. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility.
    Pediatr Infect Dis J. 2000 Dec;19(12):1163-6 PMID: 11144377
  39. Prevalence of methicillin-resistant Staphylococcus aureus colonization in surgical patients, on admission to a Welsh hospital.
    J Hosp Infect. 2002 May;51(1):43-6 PMID: 12009819
  40. Genome and virulence determinants of high virulence community-acquired MRSA.
    Lancet. 2002 May 25;359(9320):1819-27 PMID: 12044378
  41. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2003 Jan;47(1):196-203 PMID: 12499191
  42. Familial carriage of methicillin-resistant Staphylococcus aureus and subsequent infection in a premature neonate.
    Clin Infect Dis. 1995 Aug;21(2):328-32 PMID: 8562740
  43. Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission.
    Am J Med Sci. 2002 Mar;323(3):117-23 PMID: 11908855
  44. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco.
    Clin Infect Dis. 2002 Feb 15;34(4):425-33 PMID: 11797167
  45. Methicillin-resistant Staphylococcus aureus prevalence in community in the east Delhi area.
    Jpn J Infect Dis. 2003 Apr;56(2):54-6 PMID: 12824685
  46. Community-acquired methicillin-resistant Staphylococcus aureus, Finland.
    Emerg Infect Dis. 2002 Jun;8(6):602-7 PMID: 12023917
  47. Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: a 15-year longitudinal assessment in a large university-based hospital.
    Infect Control Hosp Epidemiol. 2003 Jun;24(6):403-8 PMID: 12828315
  48. Community-acquired methicillin-resistant Staphylococcus aureus infection.
    N Engl J Med. 1993 Dec 16;329(25):1896 PMID: 8247050
  49. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen.
    Infect Control Hosp Epidemiol. 2003 Jun;24(6):451-5 PMID: 12828324
  50. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections.
    Curr Opin Infect Dis. 2003 Apr;16(2):103-24 PMID: 12734443
  51. MRSA in the community.
    N Z Med J. 1996 Oct 25;109(1032):411 PMID: 8937397
  52. New methods to investigate infectious disease transmission and pathogenesis--Staphylococcus aureus disease in drug users.
    Lancet Infect Dis. 2002 Oct;2(10):605-12 PMID: 12383610
  53. Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan.
    J Infect Dis. 2002 May 15;185(10):1511-6 PMID: 11992289
  54. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals.
    J Antimicrob Chemother. 2001 Mar;47(3):277-83 PMID: 11222560
  55. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study.
    Dermatology. 1992;185(3):175-80 PMID: 1446082
  56. Community-acquired, non-multiresistant oxacillin-resistant Staphylococcus aureus (NORSA) in South Western Sydney.
    Pathology. 2001 May;33(2):206-10 PMID: 11358055
  57. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000.
    MMWR Morb Mortal Wkly Rep. 2001 Oct 26;50(42):919-22 PMID: 11699844
  58. Methicillin-resistant Staphylococcus aureus as a community organism.
    Clin Infect Dis. 1995 Nov;21(5):1308-12 PMID: 8589164
  59. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children.
    Pediatr Infect Dis J. 2001 Sep;20(9):860-3 PMID: 11734764
  60. Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clones.
    Clin Microbiol Infect. 2002 Jul;8(7):419-26 PMID: 12199852
  61. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992.
    Infect Control Hosp Epidemiol. 1994 Oct;15(10):646-51 PMID: 7844335
  62. Outbreak of boils in an Alaskan village: a case-control study.
    West J Med. 2000 Apr;172(4):235-9 PMID: 10778372
Article Info
Journal
Current infectious disease reports
Abbr.
Curr Infect Dis Rep
ISSN
1523-3847
DOI
10.1007/s11908-003-0087-6
Email
jeguia@itsa.ucsf.edu
Published
2003-12-00
Pages
459-466
Language
English
Region
United States
NLM ID
100888983
External Links
PubMed source DOI: 10.1007/s11908-003-0087-6 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2